CCMH
CRL icon

Cornerstone Capital Management Holdings’s Charles River Laboratories CRL Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$13.9M Buy
127,198
+1,231
+1% +$134K 0.1% 230
2017
Q3 		$13.6M Buy
125,967
+53,928
+75% +$5.54M 0.11% 223
2017
Q2 		$7.29M Buy
72,039
+66,178
+1,129% +$6.09M 0.06% 346
2017
Q1 		$526K Sell
5,861
-47,000
-89% -$3.99M ﹤0.01% 1048
2016
Q4 		$4.03M Sell
52,861
-193,719
-79% -$14.7M 0.03% 537
2016
Q3 		$20.5M Buy
246,580
+56,236
+30% +$4.71M 0.15% 137
2016
Q2 		$15.7M Sell
190,344
-3,419
-2% -$282K 0.13% 171
2016
Q1 		$14.7M Buy
193,763
+33,833
+21% +$2.5M 0.12% 188
2015
Q4 		$12.9M Buy
159,930
+159,911
+841,637% +$11.5M 0.11% 211
2015
Q3 		$1K Sell
19
-337
-95% -$24.2K ﹤0.01% 1480
2015
Q2 		$25K Sell
356
-5,713
-94% -$423K ﹤0.01% 1385
2015
Q1 		$481K Buy
+6,069
New +$448K ﹤0.01% 1026
2014
Q2 		– Sell
-11,986
Closed -$723K – 1322
2014
Q1 		$723K Buy
+11,986
New +$699K 0.01% 928
2013
Q3 		– Sell
-3,779
Closed -$156K – 1289
2013
Q2 		$156K Buy
+3,779
New +$162K ﹤0.01% 1088

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cornerstone Capital Management Holdings's CRL Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Charles River Laboratories (CRL) stake by 0.98% in Q4 2017, buying an estimated $134K and bringing the position to 127,198 shares worth $13.9M. The position accounts for 0.1% of the portfolio, ranked #230.

Cornerstone Capital Management Holdings first reported a position in CRL in Q2 2013 and has held it in 14 quarters since. The position peaked at $20.5M in Q3 2016. 339 funds tracked by Wall St. Rank hold CRL as of Q4 2017.

  • Cornerstone Capital Management Holdings held 127,198 shares of Charles River Laboratories worth $13.9M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 1,231 Charles River Laboratories shares in Q4 2017, an estimated $134K.
  • Charles River Laboratories made up 0.1% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #230 holding.
  • Cornerstone Capital Management Holdings first reported a position in Charles River Laboratories in Q2 2013 and has held it in 14 quarters since.
  • Cornerstone Capital Management Holdings's Charles River Laboratories position peaked at $20.5M in Q3 2016.
  • 339 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.